February 10, 2016
NIAID’s new APHRODITE clinical research trial seeks to determine if an experimental drug called CC-11050 is safe, well-tolerated, and effective in reducing inflammation in people with HIV. This Phase 1 study is being conducted at the NIH Clinical Center in Bethesda, Maryland. Participation involves about 7 visits over about 6 months. Read more at: http://www.clinicaltrials.gov/ct2/show/NCT02652546.